2022
DOI: 10.1109/jbhi.2021.3102186
|View full text |Cite
|
Sign up to set email alerts
|

Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 55 publications
(24 citation statements)
references
References 31 publications
0
23
0
Order By: Relevance
“…In multi-omics, graph convolutional neural networks have had various applications. For example, ( Peng et al , 2022 ) used them for predicting cancer drug response, and ( Wang, 2021 ; Zhang, 2021 ) used them to do biomedical classifications (e.g. Alzheimer’s disease diagnosis and pan-cancer classification, respectively).…”
Section: Discussionmentioning
confidence: 99%
“…In multi-omics, graph convolutional neural networks have had various applications. For example, ( Peng et al , 2022 ) used them for predicting cancer drug response, and ( Wang, 2021 ; Zhang, 2021 ) used them to do biomedical classifications (e.g. Alzheimer’s disease diagnosis and pan-cancer classification, respectively).…”
Section: Discussionmentioning
confidence: 99%
“…CTP heterogeneous networks are complex heterogeneous networks containing three types of edges (relations), namely C-T, T-T and T-P. For each CTP heterogeneous network, we first used the basic graph neural network model to pass messages to the nodes under each relation, and then used the heterogeneous graph convolution module [35] to aggregate the messages of the nodes under all relations by summation, with two layers of the network.…”
Section: ) Graph Neural Network Modelmentioning
confidence: 99%
“…The attention-based model captures the long-range dependency among input entities, enabling efficient neural solutions for non-Euclidean data and molecular structures. Graph Neural Networks (GNNs) introduce the community structure to multi-omic data by similarity measurement between observations, which empirically hardens the predictive performance of cancer phenotype identification [19][20][21][22][23] or treatment outcome modeling 24,25 . To this point, we observe that translation between biological problems and current methodologies is crucial for advancing AI to the new generation of cancer research, which can be done by studying the issue from a microscopic point of view.…”
Section: Introductionmentioning
confidence: 99%